KRYS: Krystal Biotech, Inc.
About
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Current Value
$176.601 Year Return
Current Value
$176.601 Year Return
Key Details
Market Cap
$5.12B
P/E Ratio
100.61
1Y Stock Return
75.65%
1Y Revenue Growth
2722.79%
Dividend Yield
0.00%
Price to Book
5.8
Strategies that include KRYS
Stock's related to KRYS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CLDX | 57.99% | $1.66B | -10.82% | 0.00% |
| ITRI | 56.69% | $5.19B | +76.91% | 0.00% |
| FRPT | 47.13% | $7.59B | +126.44% | 0.00% |
| ATUS | 44.32% | $1.10B | -0.42% | 0.00% |
| SOUN | 44.11% | $2.34B | +207.08% | 0.00% |
| BEAM | 43.03% | $2.09B | -9.52% | 0.00% |
| RXRX | 41.60% | $1.80B | -4.13% | 0.00% |
| BPMC | 41.55% | $6.01B | +42.68% | 0.00% |
| DMRC | 40.60% | $694.39M | -2.06% | 0.00% |
| SNDX | 40.44% | $1.35B | +2.87% | 0.00% |
| ALT | 38.78% | $531.30M | +194.09% | 0.00% |
| PGEN | 38.71% | $228.91M | -28.00% | 0.00% |
| ARCT | 38.16% | $489.20M | -21.27% | 0.00% |
| ACLX | 37.98% | $4.74B | +69.19% | 0.00% |
| NTLA | 36.93% | $1.44B | -50.35% | 0.00% |
| CRNX | 36.38% | $5.12B | +84.27% | 0.00% |
| XNCR | 36.23% | $1.65B | +27.73% | 0.00% |
| DNLI | 35.57% | $3.50B | +33.66% | 0.00% |
| RGNX | 35.15% | $473.65M | -51.96% | 0.00% |
| ATNM | 34.92% | $44.30M | -67.05% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ENV | 0.03% | $3.49B | +69.46% | 0.00% |
| OXBR | 0.03% | $19.05M | +178.18% | 0.00% |
| CVS | 0.07% | $70.18B | -18.08% | 4.72% |
| POR | 0.08% | $4.95B | +14.95% | 4.16% |
| GILT | 0.09% | $310.17M | -13.38% | 0.00% |
| ELV | 0.10% | $91.42B | -16.23% | 1.61% |
| POST | 0.12% | $6.45B | +28.40% | 0.00% |
| AIFU | -0.15% | $67.49M | -83.02% | 0.00% |
| SOC | -0.18% | $1.93B | +74.70% | 0.00% |
| SBLK | 0.20% | $2.38B | +2.30% | 10.64% |
| TEM | -0.20% | $8.50B | 0.00% | 0.00% |
| VSTA | 0.21% | $204.94M | -39.33% | 0.00% |
| RSG | -0.21% | $66.05B | +31.79% | 1.04% |
| LNG | 0.22% | $49.37B | +24.99% | 0.82% |
| BYND | 0.23% | $318.19M | -22.91% | 0.00% |
| EVH | 0.23% | $1.39B | -58.46% | 0.00% |
| VHC | -0.25% | $19.06M | -38.36% | 0.00% |
| NEUE | -0.26% | $40.93M | -34.13% | 0.00% |
| IP | -0.27% | $20.09B | +78.02% | 3.20% |
| CASI | 0.30% | $71.56M | -6.32% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LUNR | -13.22% | $790.33M | +333.10% | 0.00% |
| CBOE | -10.78% | $21.46B | +15.84% | 1.11% |
| D | -9.62% | $48.38B | +24.06% | 4.62% |
| KDP | -9.53% | $42.76B | -1.22% | 2.77% |
| GAN | -9.06% | $83.39M | +21.19% | 0.00% |
| CLX | -8.99% | $20.81B | +20.66% | 2.88% |
| AGR | -8.43% | $13.92B | +15.51% | 4.90% |
| KR | -8.12% | $42.03B | +35.08% | 2.11% |
| SYPR | -8.01% | $32.23M | -26.32% | 0.00% |
| PG | -8.00% | $402.15B | +14.14% | 2.33% |
| MSDL | -7.46% | $1.83B | +0.66% | 7.26% |
| PEP | -7.22% | $215.02B | -6.60% | 3.35% |
| PULM | -7.20% | $19.83M | +202.98% | 0.00% |
| PCG | -7.19% | $44.89B | +18.38% | 0.19% |
| HUSA | -7.06% | $16.69M | -11.56% | 0.00% |
| TAC | -7.05% | $3.09B | +31.01% | 1.68% |
| TPST | -6.94% | $37.75M | -77.59% | 0.00% |
| FDP | -6.78% | $1.62B | +45.67% | 2.97% |
| BTCT | -6.59% | $42.61M | +353.33% | 0.00% |
| HSY | -6.29% | $34.45B | -10.68% | 3.21% |
ETF's related to KRYS
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| QQA | 57.33% | $135.01M | 0% |
| XBI | 54.96% | $6.58B | 0.35% |
| RSPA | 53.26% | $273.87M | 0% |
| PTH | 51.57% | $143.31M | 0.6% |
| PBE | 48.81% | $258.53M | 0.58% |
| ARKG | 46.63% | $1.13B | 0.75% |
| IBB | 46.30% | $6.66B | 0.45% |
| GNOM | 45.54% | $70.59M | 0.5% |
| KOMP | 44.32% | $2.09B | 0.2% |
| IPO | 43.94% | $157.08M | 0.6% |
| IWO | 43.40% | $12.56B | 0.24% |
| IWC | 42.98% | $933.99M | 0.6% |
| ARKK | 42.17% | $6.28B | 0.75% |
| FBT | 42.13% | $1.11B | 0.56% |
| ROBT | 41.55% | $441.35M | 0.65% |
| VBK | 41.30% | $19.31B | 0.07% |
| ITEQ | 41.21% | $84.84M | 0.75% |
| FFTY | 41.05% | $67.59M | 0.8% |
| ISCG | 40.92% | $640.00M | 0.06% |
| VTWO | 40.43% | $12.38B | 0.1% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IYK | 0.38% | $1.30B | 0.4% |
| CGSM | -0.47% | $514.53M | 0.25% |
| HDRO | -1.12% | $164.26M | 0.3% |
| SOYB | -1.13% | $27.32M | 0.22% |
| HIGH | -1.19% | $302.78M | 0.51% |
| BOXX | 1.22% | $4.43B | 0.1949% |
| MUST | 1.24% | $410.00M | 0.23% |
| SHV | -1.31% | $18.13B | 0.15% |
| CLOI | -1.44% | $715.40M | 0.4% |
| CSHI | 1.56% | $482.85M | 0.38% |
| DBA | 1.64% | $755.88M | 0.93% |
| CORN | -1.70% | $61.12M | 0.2% |
| CCOR | -1.72% | $109.04M | 1.18% |
| DBMF | 2.51% | $1.02B | 0.85% |
| GBIL | 2.59% | $5.60B | 0.12% |
| XHLF | -2.72% | $874.27M | 0.03% |
| VNLA | 2.82% | $2.27B | 0.23% |
| BSCO | 2.89% | $2.35B | 0.1% |
| EQLS | -3.00% | $76.08M | 1% |
| DFNM | 3.10% | $1.40B | 0.17% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -33.52% | $388.04M | 1.43% |
| VIXY | -25.73% | $195.31M | 0.85% |
| UUP | -15.50% | $309.25M | 0.77% |
| TAIL | -14.82% | $67.98M | 0.59% |
| USDU | -13.38% | $201.97M | 0.5% |
| TPMN | -12.53% | $40.60M | 0.65% |
| CTA | -8.32% | $350.27M | 0.78% |
| IBHD | -7.43% | $327.80M | 0.35% |
| KMLM | -7.04% | $353.87M | 0.9% |
| MSOS | -6.48% | $632.80M | 0.83% |
| SGOV | -5.93% | $27.53B | 0.09% |
| AGZD | -5.39% | $142.76M | 0.23% |
| BILZ | -5.26% | $563.02M | 0.14% |
| XBIL | -5.18% | $637.70M | 0.15% |
| KCCA | -5.04% | $220.51M | 0.87% |
| WEAT | -4.83% | $120.27M | 0.28% |
| YEAR | -4.63% | $1.13B | 0.25% |
| MINT | -4.60% | $11.62B | 0.35% |
| TBIL | -3.23% | $4.38B | 0.15% |
| EQLS | -3.00% | $76.08M | 1% |
News
Yahoo
Over the last 7 days, the United States market has risen 5.7%, contributing to a remarkable 37% increase over the past year, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable market conditions.
Yahoo
PITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Stifel 2024 Healthcare Conference on November 18, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:55 am ET and host investor meetings throughout the day. A webcast of the presentation will be available here beginning at 10:
Yahoo
As U.S. markets reach record highs fueled by post-election optimism, investors are increasingly focused on identifying growth opportunities that align with the current economic landscape. In this context, companies with strong insider ownership can be particularly appealing, as they often signal confidence from those who know the business best and may offer potential resilience amid market fluctuations.
Yahoo
It's been a good week for Krystal Biotech, Inc. ( NASDAQ:KRYS ) shareholders, because the company has just released its...
Yahoo
PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation Conference on November 12, 2024, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:30 pm ET and host investor meetings throughout the day. A webcast of the presentation will be available her
Yahoo
KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek's launch in the United States shows strong uptake.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.